Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - the procedure pack consists of: -medicine vial and diluent -mix-2-vial (filter transfer set), -venipuncture set, -disposable syringe, -alcohol swabs and -plaster/adhesive bandage. the mix-2-vial is used to transfer the diluent from the diluent vial to the medicine vial. the reconstituted medicine is drawn through the mix-2-vial into the syringe. the syringe containing the medicine is then connected to the venipuncture set to facilitate intravenous injection of the medicine. alcohol swabs are provided to wipe the rubber stopper of each vial before the mix-2-vial is applied. the plaster/adhesive bandage is provided to cover the injection site after administration of medicine.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - 41222 - medication transfer set - the procedure pack consists of a transfer device, diluent vial and medicine vial. the transfer device is to facilitate the transfer of the diluent from the vial into the lyophilised medicine vial for reconstitution.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - 41222 - medication transfer set - this procedure pack consist of a medicine vial, a diluent vial and a transfer device. the transfer device is to facilitate the transfer of the diluent from the vial into the lyophilised medicine vial for reconstitution.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - 41222 - medication transfer set - the procedure pack consists of a transfer set, syringe filter, dispensing pin, diluent vial and medicine vial. the transfer device is to facilitate the transfer of the diluent from the vial into the lyophilised medicine vial for reconstitution. the remaining components are to facilitate withdrawal and filtering of the reconstituted product into a syringe prior to administration.

Israel - engelsk - Ministry of Health

csl behring ltd., israel - albutrepenonacog alfa - powder and solvent for solution for injection - albutrepenonacog alfa 1000 iu - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

Israel - engelsk - Ministry of Health

csl behring ltd., israel - albutrepenonacog alfa - powder and solvent for solution for injection - albutrepenonacog alfa 2000 iu - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

Israel - engelsk - Ministry of Health

csl behring ltd., israel - albutrepenonacog alfa - powder and solvent for solution for injection - albutrepenonacog alfa 500 iu - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

Israel - engelsk - Ministry of Health

csl behring ltd., israel - factor xiii - powder and solvent for solution for injection/solution for infusion - factor xiii 200 - 320 iu - coagulation factor xiii - coagulation factor xiii - fibrogammin is indicated for adult and paediatric patients • for prophylactic treatment of congenital fxiii deficiency and • for peri-operative management of surgical bleeding with congentital fxiii deficiency. fibrogammin is furthermore indicated • for haemorrhagic diatheses caused completely or in part by acquired fxiii deficiency • for supportive therapy in case of disturbance in wound healing, especially in ulcus cruris, after large surgery or injuries.

Israel - engelsk - Ministry of Health

csl behring ltd., israel - factor xiii - powder and solvent for solution for injection/solution for infusion - factor xiii 1250 iu - coagulation factor xiii - coagulation factor xiii - fibrogammin is indicated for adult and paediatric patients • for prophylactic treatment of congenital fxiii deficiency and • for peri-operative management of surgical bleeding with congentital fxiii deficiency. fibrogammin is furthermore indicated • for haemorrhagic diatheses caused completely or in part by acquired fxiii deficiency • for supportive therapy in case of disturbance in wound healing, especially in ulcus cruris, after large surgery or injuries.

Singapore - engelsk - HSA (Health Sciences Authority)

csl behring pte. ltd. - lonoctocog alfa - injection, powder, lyophilized, for solution - lonoctocog alfa 1000iu/vial